14Oct 2021
BRCA1 promoter hypermethylation on circulating tumor DNA correlates with improved survival of patients with ovarian cancer

BRCA1 promoter hypermethylation on circulating tumor DNA correlates with improved survival of patients with ovarian cancer

In patients with ovarian cancer (OC) undergoing platinum‐based chemotherapy and PARP‐inhibitor treatment, BRCA1 deficiency is used as major predictive marker for estimating response to therapy. Here, we present a highly sensitive and specific liquid biopsy assay that assesses BRCA1 gene promoter hypermethylation on circulating tumor DNA (ctDNA) isolated from blood plasma. Our results suggest that hypermethylation and methylation conversion of the BRCA1 promoter in ctDNA are independently correlated to longer progression‐free survival of patients with OC...

  • #oncology

Like

Save

Share